Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 75.00
-2.00 (-2.60%)
Jul 16, 2026, 9:59 AM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 5.89 billion as of July 15, 2026. Its market cap has decreased by -43.16% in one year.
Market Cap
5.89B
Enterprise Value
4.84B
Revenue
601.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
75.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 5.89B, an increase of 1,153.63%. That is a compound annual growth rate of 18.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 5.89B | -19.07% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADR Biomedical Holdings | 7.15B |
| MEDINET | 7.00B |
| Carna Biosciences | 6.96B |
| BrightPath Biotherapeutics | 6.94B |
| CellSource | 6.85B |
| Noile-Immune Biotech | 5.82B |
| PRISM BioLab Co.,LTD | 5.69B |
| Soiken Holdings | 5.60B |